Vogue Commercial Co. Ltd Live Quote-Abbott India Ltd | BFSL
Reach out to us on 0120-4918900 Or
Get a call back Click here

Markets

Share Price

ABBOTT INDIA LTD.

  • NSE CodeABBOTINDIAEQ
  • BSE Code500488
  • ISININE358A01014
  • IndustryPharmaceuticals

Company Information

Management

Ms. Sangeeta Shetty

Co. Secretary & Compl. Officer

Ms. Maithilee Mistry

Chief Financial Officer

Mr. Devesh Choudhari

Director - Finance

Mr. Prithwish Banerji

Commercial Director

Incorporation Year

22/08/1944

Registered Address


Mumbai, Maharashtra - 400071
Tel: 022-67978888
Fax: 022-67978727

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

investorrelations.india@abbott.com

Website

http://www.abbott.co.in

Listing

BSE, MCXSX, NSE

Corporate News

Abbott India Ltd. - Intimation Under Regulation 30 Of...

31-Dec-2025|12:29PM

Intimation under Regulation 30 of the Securities and Exchange Board of Indi

Abbott India Ltd. - Announcement under Regulation 30 ...

24-Dec-2025|7:49PM

Appointment of Mr. Vivek Mohan (DIN : 00075006) as Additional (Non-Executiv

Abbott India Ltd. - Announcement under Regulation 30 ...

25-Nov-2025|6:02PM

Change in Senior Management Personnel.

Abbott India Ltd. - Approval Of Central Government Fo...

24-Nov-2025|1:59PM

Approval of Central Government for appointment of Managing Director

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug66.34188.10
Aarti Drug410.953,750.74
Aarti Pharma742.106,726.94
Abbott India28,125.0059,763.66
Accent Micro348.75836.62
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
SBI Large &am..826.702.23
Axis Midcap F..496.361.54
Canara Robeco..435.591.66
Nippon India ..263.110.53
SBI Innovativ..258.784.13
More

Board Meetings

DatePurpose
06/11/2025Quarterly Results
12/08/2025Quarterly Results
15/05/2025Audited Results & F..
05/02/2025Quarterly Results
07/11/2024Quarterly Results
More